| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S13402-018-0379-3 |
| P698 | PubMed publication ID | 29633150 |
| P50 | author | André M Travessa | Q61108129 |
| Rafaela Lacerda | Q88313752 | ||
| Ana Rita Neves | Q88313754 | ||
| P2093 | author name string | Joana Silva | |
| Ana Rita Marques | |||
| Luísa Romão | |||
| Ana Sousa | |||
| Raquel Rodrigues | |||
| Patrícia Pinho | |||
| Vânia Gonçalves | |||
| Rafael Fernandes | |||
| Paulo J da Costa | |||
| Sónia Custódio | |||
| Bruna F Pereira | |||
| Eva Rolo | |||
| Gonçalo R Nogueira | |||
| Inês Teles Siefers Alves | |||
| Manuel Condinho | |||
| Patrícia Martins-Dias | |||
| Rosário Pinto Leite | |||
| P2860 | cites work | Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. | Q52846906 |
| Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. | Q52941950 | ||
| Alternative splicing within the Wnt signaling pathway: role in cancer development. | Q53211105 | ||
| Communicating risk under conditions of uncertainty: not as simple as it may seem | Q83439563 | ||
| Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery | Q86203470 | ||
| Structural organization and splice variants of the POLE1 gene encoding the catalytic subunit of human DNA polymerase epsilon | Q24531474 | ||
| Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas | Q24617520 | ||
| The NMR solution structures of the five constituent cold-shock domains (CSD) of the human UNR (upstream of N-ras) protein | Q27660159 | ||
| Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
| Mechanical devices of the spliceosome: motors, clocks, springs, and things | Q27938081 | ||
| The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery | Q28077234 | ||
| Comprehensive proteomic analysis of the human spliceosome | Q28201545 | ||
| PD-1 Blockade in Tumors with Mismatch-Repair Deficiency | Q28262647 | ||
| Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing | Q28275103 | ||
| Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged | Q28297381 | ||
| Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways | Q28533401 | ||
| The Path to Personalized Medicine | Q29541502 | ||
| Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing | Q29547470 | ||
| Alternative pre-mRNA splicing and proteome expansion in metazoans | Q29618540 | ||
| From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and "augmented" medicine: some considerations on Salvatore Iaconesi's clinical story | Q30430213 | ||
| Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies | Q30436867 | ||
| Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors | Q33618407 | ||
| Personalized medicine: part 1: evolution and development into theranostics | Q34214536 | ||
| Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors | Q34419716 | ||
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. | Q34557699 | ||
| Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. | Q36058262 | ||
| Foundations, promises and uncertainties of personalized medicine | Q36828011 | ||
| Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients | Q37089636 | ||
| A cost analysis of a cancer genetic service model in the UK | Q37124110 | ||
| Systematic analysis of posttranscriptional gene expression | Q37787996 | ||
| Family history and women with ovarian cancer: is it asked and does it matter?: An observational study | Q37978471 | ||
| RNA-binding proteins, multifaceted translational regulators in cancer. | Q38260294 | ||
| RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation | Q39044270 | ||
| Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation | Q39348799 | ||
| The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease. | Q39458148 | ||
| RNA binding specificity of Unr, a protein with five cold shock domains | Q39727855 | ||
| Tumor suppressor properties of the splicing regulatory factor RBM10. | Q40517060 | ||
| Personalized medicine: Time for one-person trials | Q46268988 | ||
| Keeping it simple: genetics referrals for all invasive serous ovarian cancers | Q46601235 | ||
| Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling | Q47113855 | ||
| UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis. | Q51291537 | ||
| Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. | Q52087016 | ||
| P433 | issue | 3 | |
| P921 | main subject | rare disease | Q929833 |
| personalized medicine | Q2072214 | ||
| P304 | page(s) | 335-341 | |
| P577 | publication date | 2018-04-09 | |
| P1433 | published in | Cellular Oncology | Q2160503 |
| P1476 | title | Genetics of personalized medicine: cancer and rare diseases | |
| P478 | volume | 41 |
Search more.